Additional information
| Active substance | Empagliflozin |
|---|---|
| Water Retention | Can lead to a reduction in overall body water content |
| Hepatotoxicity | Low risk |
| Lab Test | Monitoring of renal function and blood glucose levels |
| Strength | 10mg |
| Also known as | Empa |
| Blood pressure | Can cause a modest reduction in blood pressure |
| Trade name | Jardiance |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
| Formula | C23H27ClO7 |
| Substance class | Sodium-glucose co-transporter 2 (SGLT2) inhibitor |
| Main action | Reduces blood glucose by inhibiting glucose reabsorption in the kidney |
| Half-life | Approximately 12.4 hours |
| Dosage (medical) | Typically 10 mg once daily, may be increased to 25 mg based on patient's condition and response |
| Dosage (sports) | Not applicable as it is not used for enhancing athletic performance |
| Effects | Lowers blood sugar levels, aids in weight loss, and reduces blood pressure and cardiovascular risks |
| Side effects | Urinary tract infections, genital infections, increased urination, dehydration, hypotension |
| Use in sports | Not typically used in sports due to its mechanism focused on lowering blood glucose levels |
| Manufacturer | Boehringer Ingelheim Pvt. Ltd. |
| Packing | 10 tabs/blister |
Norvacs 5 mg Pfizer
Balkan Pharma Strombafort 10mg 100 Tabletten
Spiriva HandiHaler 18mg Boehringer Ingelheim
AVELOX 400 Bayer
Fostimon (Merional) 150 IU HMG IBSA
Tavanic 500 mg Sanofi 




Reviews
There are no reviews yet.